| 日付 |
時間 |
ソース |
タイトル |
|---|
| 2024/4/23 | 20:25 | IHMARKETNEWS | Apple Loses Market Share in China, GM Surges in Pre-Market.. |
| 2024/4/16 | 03:00 | PRNUS | New Novartis Fabhalta® (iptacopan) data show clinically.. |
| 2024/4/11 | 20:00 | GLOBE | Arvinas Enters into a Transaction with Novartis, including a.. |
| 2024/4/10 | 20:13 | IHMARKETNEWS | Delta Generates US$37 Million Profit in Q1, Google and Intel.. |
| 2024/4/07 | 05:16 | PRNUS | New Novartis data show early addition of twice-yearly*.. |
| 2024/2/16 | 06:15 | EDGAR2 | Form S-8 POS - Securities to be offered to employees in.. |
| 2024/2/07 | 06:52 | EDGAR2 | Form SC TO-C - Written communication relating to an issuer.. |
| 2024/2/06 | 20:14 | IHMARKETNEWS | Boeing Faces Strike Threat, Palantir Up 18% After Recording.. |
| 2024/2/06 | 07:06 | EDGAR2 | Form SC TO-C - Written communication relating to an issuer.. |
| 2024/2/03 | 04:18 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 2024/1/31 | 21:44 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 2024/1/31 | 21:43 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 2024/1/31 | 21:42 | EDGAR2 | Form IRANNOTICE - Notice of disclosure filed pursuant to.. |
| 2024/1/31 | 21:38 | EDGAR2 | Form 20-F - Annual and transition report of foreign private.. |
| 2024/1/31 | 20:28 | IHMARKETNEWS | Walmart’s Stock Split, Elon Musk’s Billion-Dollar Package.. |
| 2024/1/22 | 15:59 | DJN | Sandoz to Acquire Cimerli Business from Coherus for $170.. |
| 2024/1/12 | 20:10 | IHMARKETNEWS | Wall Street Highlights: DocuSign Acquisition Battle, Tesla.. |
| 2024/1/12 | 03:02 | DJN | Cytokinetics Shares Slide as Novartis Reportedly Shies Away.. |
| 2024/1/09 | 03:43 | DJN | Cytokinetics Shares Jump 16% After WSJ Report of Novartis.. |
| 2024/1/09 | 00:41 | DJN | Novartis on Track for Record High Close -- Data Talk |
| 2024/1/08 | 20:13 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 2024/1/08 | 16:01 | DJN | Novartis's Scemblix Drug Meets Main Goals in Late-Stage.. |
| 2024/1/06 | 00:15 | DJN | Novartis to Make Pluvicto Radioligand Therapy at.. |
| 2024/1/02 | 21:46 | DJN | Voyager Therapeutics Shares Leap Premarket on Novartis.. |
| 2023/12/11 | 20:05 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 2023/12/11 | 16:02 | DJN | Novartis Drug Meets Primary Goal in Late-Stage Study for.. |
| 2023/12/11 | 09:39 | PRNUS | Novartis presents new 48-week results from Phase III.. |
| 2023/12/06 | 19:14 | DJN | Merck Shares Slump After Multiple Sclerosis Drug Fails in.. |
| 2023/12/06 | 14:18 | PRNUS | Novartis receives FDA approval for Fabhalta® (iptacopan),.. |
| 2023/12/05 | 20:25 | IHMARKETNEWS | Moody’s Reassesses China, GitLab Exceeds Estimates, Twilio.. |
| 2023/11/29 | 20:18 | IHMARKETNEWS | Amazon Unveils Innovative Services, Okta Discloses Data.. |
| 2023/11/29 | 05:08 | DJN | FDA Looking Into All Approved CAR T Therapies on Risk of.. |
| 2023/11/28 | 20:10 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 2023/11/28 | 16:12 | DJN | Novartis Raises Mid-Term Sales Growth Targets |
| 2023/11/13 | 23:16 | DJN | Legend Biotech Subsidiary in License Agreement With Novartis |
| 2023/11/01 | 21:45 | IHNW | Get Ready for Next Generation of Diabetes, Weight-Management.. |
| 2023/11/01 | 15:43 | DJN | Novartis Skin Treatment Drug Cosentyx Gets US FDA Approval |
| 2023/10/30 | 19:05 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 2023/10/30 | 16:07 | DJN | Novartis to Seek US Accelerated Approval of Atrasentan After.. |
| 2023/10/27 | 14:45 | DJN | Novartis Says FDA Deems Pluvicto Shortage Resolved, Supply.. |
| 2023/10/24 | 20:22 | IHMARKETNEWS | Tuesday’s Wall Street Highlights: Coinbase, Intel, Redfin,.. |
| 2023/10/24 | 19:33 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 2023/10/24 | 16:32 | DJN | Novartis Raises Earnings Guidance Again After Key Drugs.. |
| 2023/10/24 | 14:48 | DJN | Novartis Raises Earnings Guidance After Key Drugs Boost.. |
| 2023/10/07 | 06:11 | DJN | Novartis Gets FDA Approval IV Formulation of Cosentyx |
| 2023/10/04 | 19:57 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 2023/10/04 | 18:17 | DJN | Novartis Spinoff Sandoz Group Valued at $11.2 Billion in.. |
| 2023/10/02 | 19:05 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 2023/10/02 | 15:10 | DJN | Novartis Says Kidney Drug Phase 3 Trial Reaches Positive.. |
| 2023/9/26 | 15:03 | DJN | Novartis's Sandoz to Commercialize Multiple Sclerosis.. |
Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
